Craft

Greenyn Biotechnology

Stock Price

NT$78.5

2024-10-29

Market Capitalization

NT$2.1 B

2024-10-28

Revenue

NT$915.3 M

FY, 2025

Greenyn Biotechnology Summary

Company Summary

Overview
Greenyn Biotechnology is a company that manufactures health supplement raw materials. It offers proprietary ingredients such as Insumate, a bitter melon extract, Antromax, antrodia cinnamomea, dosages, etc. The company provides clinical planning, customization, technology development, optimization, and other services.
Type
Public
Status
Active
Founded
2012
HQ
TW | view all locations
Website
https://www.greenynbio.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Taichung City HQ

    Taiwan

    5th floor, No. 23-43, Keya Rd, Daya District

Greenyn Biotechnology Financials

Summary Financials

Revenue (FY, 2025)
NT$915.3M
Gross profit (FY, 2025)
NT$477.8M
Net income (FY, 2025)
NT$145.5M
Cash (FY, 2025)
NT$793.4M
EBIT (FY, 2025)
NT$190.9M
Enterprise value
$2.2B

Footer menu